Posted by ABMN Staff on Apr 18th, 2024
HC Wainwright reissued their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a research report released on Wednesday, Benzinga reports. The firm currently has a $7.00 price target on the stock.
Separately, Benchmark...
More of this article »